Daily News header
Press Release

Hot Topic, Inc. Reports Holiday 2012 Comp Sales Up 2.2%

CITY OF INDUSTRY, Calif. - (BUSINESS WIRE) - Hot Topic, Inc. (NASDAQ Global Select Market: HOTT) today announced the sales results for the combined November/December "Holiday" period (nine weeks ended December 29, 2012). A summary of the sales results by division (including Internet) is as follows:

Comparable
Sales % Change * Net Sales
% Change
This Last $ To Last
Year Year Millions Year
HOLIDAY:
Hot Topic 1.6 % 2.7 % $ 141.1 0.8 %
Torrid 5.5 % -2.2 % $ 36.2 18.8 %
Total Co. 2.2 % 1.8 % $ 177.3 4.0 %

YEAR TO DATE:

Hot Topic 3.5 % 0.5 % $ 514.2 1.7 %
Torrid 3.0 % 4.1 % $ 171.8 12.3 %
Total Co. 3.4 % 1.3 % $ 686.0 4.2 %

* During the first quarter of fiscal 2012, Hot Topic, Inc. began including Internet sales in the computation of comparable sales. All prior year comparable sales results have been adjusted to reflect this change.

The company reiterated its previously announced fourth quarter earnings guidance (14 weeks ending February 2, 2013) in the range of $0.23 to $0.27 per share, as compared to earnings per share of $0.21 last year. This guidance is based upon a comp sales increase in the low to mid-single-digit percentage range. In addition, the company announced initial 2013 earnings guidance (52 weeks ending February 1, 2014) to be in the range of an increase of 30 to 35% over fiscal 2012 based upon a comp sales increase in the low-single-digit range.

To read the complete release at NewsBlaze,
Hot Topic, Inc. Reports Holiday 2012 Comp Sales Up 2.2%,
Click here

Related Business Wire News

RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
Intelligent Energy is working with Etisalat Nigeria to test personal energy devices powered by Intelligent Energy's proven fuel cell technology, with an Etisalat user trial to commence this quarter.
Novo A/S, a holding company of the Novo Group has acquired anti-infective developers and manufacturers Xellia Pharmaceuticals for US$ 700 million
InVivo Therapeutics Holdings Corp. , a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that an interview with InVivo Chief Executive Officer Frank Reynolds is ...
ASCC Forecasts Big Growth This Summer
Kineta, Seattle biotech, announces large investment from Hydra LLC, a group of former Glencore oil and gas traders

 

NewsBlaze Writers Of The Month



Popular Stories This Month

newsletter logo

NewsBlaze
Copyright © 2004-2013 NewsBlaze Pty. Ltd.
Use of this website is subject to our Terms of Service and Privacy Policy  | DMCA Notice               Press Room   |    Visit NewsBlaze Mobile Site